GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clinica Baviera SA (XMAD:CBAV) » Definitions » Cyclically Adjusted PS Ratio

Clinica Baviera (XMAD:CBAV) Cyclically Adjusted PS Ratio : 2.98 (As of Jun. 10, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Clinica Baviera Cyclically Adjusted PS Ratio?

As of today (2024-06-10), Clinica Baviera's current share price is €28.00. Clinica Baviera's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €9.41. Clinica Baviera's Cyclically Adjusted PS Ratio for today is 2.98.

The historical rank and industry rank for Clinica Baviera's Cyclically Adjusted PS Ratio or its related term are showing as below:

XMAD:CBAV' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.34   Med: 2.33   Max: 3.48
Current: 2.98

During the past years, Clinica Baviera's highest Cyclically Adjusted PS Ratio was 3.48. The lowest was 1.34. And the median was 2.33.

XMAD:CBAV's Cyclically Adjusted PS Ratio is ranked worse than
54.96% of 131 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.5 vs XMAD:CBAV: 2.98

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Clinica Baviera's adjusted revenue per share data for the three months ended in Mar. 2024 was €4.074. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €9.41 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Clinica Baviera Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Clinica Baviera's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinica Baviera Cyclically Adjusted PS Ratio Chart

Clinica Baviera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.40 2.31 3.05 2.19 2.54

Clinica Baviera Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.26 2.14 2.35 2.54 3.01

Competitive Comparison of Clinica Baviera's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Clinica Baviera's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinica Baviera's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Clinica Baviera's Cyclically Adjusted PS Ratio falls into.



Clinica Baviera Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Clinica Baviera's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=28.00/9.41
=2.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinica Baviera's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Clinica Baviera's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.074/122.7621*122.7621
=4.074

Current CPI (Mar. 2024) = 122.7621.

Clinica Baviera Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.223 101.081 1.485
201409 1.086 100.441 1.327
201412 1.434 100.251 1.756
201503 1.336 99.474 1.649
201506 1.257 101.138 1.526
201509 1.140 99.559 1.406
201512 1.514 100.268 1.854
201603 1.491 98.638 1.856
201606 1.431 100.333 1.751
201609 1.204 99.737 1.482
201612 1.498 101.842 1.806
201703 1.522 100.896 1.852
201706 1.554 101.848 1.873
201709 1.362 101.524 1.647
201712 1.688 102.975 2.012
201803 1.748 102.122 2.101
201806 1.697 104.165 2.000
201809 1.419 103.818 1.678
201812 1.839 104.193 2.167
201903 1.822 103.488 2.161
201906 1.985 104.612 2.329
201909 1.670 103.905 1.973
201912 2.150 105.015 2.513
202003 1.804 103.469 2.140
202006 1.245 104.254 1.466
202009 2.011 103.521 2.385
202012 2.467 104.456 2.899
202103 2.527 104.857 2.958
202106 2.778 107.102 3.184
202109 2.355 107.669 2.685
202112 2.934 111.298 3.236
202203 3.213 115.153 3.425
202206 3.070 118.044 3.193
202209 2.581 117.221 2.703
202212 3.297 117.650 3.440
202303 3.643 118.948 3.760
202306 3.467 120.278 3.539
202309 2.924 121.343 2.958
202312 3.762 121.300 3.807
202403 4.074 122.762 4.074

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Clinica Baviera  (XMAD:CBAV) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Clinica Baviera Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Clinica Baviera's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Clinica Baviera (XMAD:CBAV) Business Description

Traded in Other Exchanges
Address
Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.

Clinica Baviera (XMAD:CBAV) Headlines

No Headlines